Market Overview

FDA's Orange Book Doesn't Include Amarin's Vascepa NCE Status in November Report - Bloomberg

Share:
Related AMRN
Mid-Morning Market Update: Markets Mostly Flat; Accenture Posts In-Line Q3 Earnings
Watch These 8 Huge Call Purchases In Wednesday Trade

View Orange Book.

Posted-In: News FDA

 

Related Articles (AMRN)

View Comments and Join the Discussion!